Association of systemic lupus erythematosus with angiographically defined coronary artery disease: A retrospective cohort study

Arthritis Care and Research

Volumn 65, Issue 2, 2013, Pages 266-273

  Kaul, Mala S ^a   Rao, Sunil V ^a   Shaw, Linda K ^a   Honeycutt, Emily ^a   Ardoin, Stacy P ^b   St Clair, E William ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NORTH CAROLINA; RETROSPECTIVE STUDIES;

EID: 84873131632     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21782     Document Type: Article

References (22)

1. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J,. Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259-64.
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
3. Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A,. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 924-9.
4. Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR,. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93: 198-200.
5. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH,. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the Nurses' Health Study. Arthritis Rheum 2009; 61: 1396-402.
6. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331-7.
7. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-15.
8. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-406.
9. El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399-404.
10. Bulkley BH, Roberts WC,. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975; 58: 243-64.
11. Nikpour M, Urowitz MB, Gladman DD, Ibanez D, Harvey P, Iwanochko RM,. Relationship between myocardial perfusion scintigraphy and brachial artery endothelial function in systemic lupus erythematosus [abstract]. Arthritis Rheum 2004; 50: 4089-90.
12. Sella EM, Sato EI, Barbieri A,. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy. Arthritis Rheum 2003; 48: 3168-75.
13. Nikpour M, Urowitz MB, Gladman DD,. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 329-54.
14. McAlindon TE, Formica M, Palmer JR, Lafyatis R, Rosenberg L,. Assessment of strategies for identifying diagnosed cases of systemic lupus erythematosus through self-report. Lupus 2003; 12: 754-9.
15. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
17. Califf RM, Harrell FE Jr, Lee KL, Rankin JS, Hlatky MA, Mark DB, et al. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA 1989; 261: 2077-86.
18. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-68.
19. Frostegard J,. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005; 257: 485-95.
20. Haque S, Gordon C, Isenberg D, Rahman A, Lanyon P, Bell A, et al. Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the Lupus and Atherosclerosis Evaluation of Risk (LASER) Study. J Rheumatol 2010; 37: 322-9.
21. Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 2007; 16: 731-5.
22. Cortes S, Chambers S, Jeronimo A, Isenberg D,. Diabetes mellitus complicating systemic lupus erythematosus: analysis of the UCL lupus cohort and review of the literature. Lupus 2008; 17: 977-80.